Ilaria Bonavita
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ilaria Bonavita has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Gemma Piella
BCN MedTech, Department of Engineering, Universitat Pompeu Fabra, Barcelona, Spain
3 shared publications - Mario Ceresa
European Commission, Joint Research Centre (JRC), Ispra, Italy
3 shared publications - Miguel Angel Gonzalez Ballester
BCN MedTech, Department of Engineering, Universitat Pompeu Fabra, Barcelona, Spain
3 shared publications - Vicent Ribas
Eurecat, Centre Tecnològic de Catalunya, 08005 Barcelona, Spain
3 shared publications - Xavier Rafael-Palou
Eurecat, Centre Tecnològic de Catalunya, eHealth Unit, Barcelona, Spain; BCN Medtech, Dept. of Information and Communication Technologies, Universitat Pompeu Fabra, Barcelona, Spain
3 shared publications - Anton Aubanell
Hospital de Sant Pau i la Santa Creu, Diagnostic Imaging Department, Barcelona, Spain
1 shared publication
Latest Publications
- Open Access
Pulmonary Nodule Malignancy Classification Using its Temporal Evolution with Two-Stream 3D Convolutional Neural Networks
Nodule malignancy assessment is a complex, time-consuming and error-prone task. Current clinical practice requires measuring changes in size and density of the nodule at different time-points. State of the art solutions rely on 3D convolutional neural networks built on pulmonary nodules obtained from single CT scan per patient. In this work, we propose a two-stream 3D convolutional neural network that predicts malignancy by jointly analyzing two pulmonary nodule volumes from the same patient taken at different time-points. Best results achieve 77% of F1-score in test with an increment of 9% and 12% of F1-score with respect to the same network trained with images from a single time-point.
Open AccessPulmonary Nodule Malignancy Classification Using its Temporal Evolution with Two-Stream 3D Convolutional Neural Networks
Nodule malignancy assessment is a complex, time-consuming and error-prone task. Current clinical practice requires measuring changes in size and density of the nodule at different time-points. State of the art solutions rely on 3D convolutional neural networks built on pulmonary nodules obtained from single CT scan per patient. In this work, we propose a two-stream 3D convolutional neural network that predicts malignancy by jointly analyzing two pulmonary nodule volumes from the same patient taken at different time-points. Best results achieve 77% of F1-score in test with an increment of 9% and 12% of F1-score with respect to the same network trained with images from a single time-point.
- 1 March 2020
- Published by Elsevier in Computer Methods and Programs in Biomedicine
- Vol. 185, 105172
Integration of convolutional neural networks for pulmonary nodule malignancy assessment in a lung cancer classification pipeline
- 1 March 2020
- Published by Elsevier in Computer Methods and Programs in Biomedicine
- Vol. 185, 105172
Integration of convolutional neural networks for pulmonary nodule malignancy assessment in a lung cancer classification pipeline
- Open Access
Integration of Convolutional Neural Networks for Pulmonary Nodule Malignancy Assessment in a Lung Cancer Classification Pipeline
The early identification of malignant pulmonary nodules is critical for better lung cancer prognosis and less invasive chemo or radio therapies. Nodule malignancy assessment done by radiologists is extremely useful for planning a preventive intervention but is, unfortunately, a complex, time-consuming and error-prone task. This explains the lack of large datasets containing radiologists malignancy characterization of nodules. In this article, we propose to assess nodule malignancy through 3D convolutional neural networks and to integrate it in an automated end-to-end existing pipeline of lung cancer detection. For training and testing purposes we used independent subsets of the LIDC dataset. Adding the probabilities of nodules malignity in a baseline lung cancer pipeline improved its F1-weighted score by 14.7%, whereas integrating the malignancy model itself using transfer learning outperformed the baseline prediction by 11.8% of F1-weighted score. Despite the limited size of the lung cancer datasets, integrating predictive models of nodule malignancy improves prediction of lung cancer.
Open AccessIntegration of Convolutional Neural Networks for Pulmonary Nodule Malignancy Assessment in a Lung Cancer Classification Pipeline
The early identification of malignant pulmonary nodules is critical for better lung cancer prognosis and less invasive chemo or radio therapies. Nodule malignancy assessment done by radiologists is extremely useful for planning a preventive intervention but is, unfortunately, a complex, time-consuming and error-prone task. This explains the lack of large datasets containing radiologists malignancy characterization of nodules. In this article, we propose to assess nodule malignancy through 3D convolutional neural networks and to integrate it in an automated end-to-end existing pipeline of lung cancer detection. For training and testing purposes we used independent subsets of the LIDC dataset. Adding the probabilities of nodules malignity in a baseline lung cancer pipeline improved its F1-weighted score by 14.7%, whereas integrating the malignancy model itself using transfer learning outperformed the baseline prediction by 11.8% of F1-weighted score. Despite the limited size of the lung cancer datasets, integrating predictive models of nodule malignancy improves prediction of lung cancer.